Key facts
- Notable investors include Zoic Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Descartes Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for Descartes Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Descartes Bio
Provider of advanced biotechnological manufacturing services intended to research and develop applications of biologics and novel modalities. The company specializes in microbial fermentation, mammalian cell culture, chemical synthesis, and enzymatic production to offer early-stage development, small batch production, clinical trials, and production capabilities, enabling biopharmaceutical companies to mitigate risks and ensure efficient production and distribution.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Website
- biodescartes.com/
- Ownership
- Privately Held (backing)
Descartes Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Descartes Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Descartes Bio in its N-PORT filings yet. We sweep new filings monthly.